<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0191560</article-id>
<article-id pub-id-type="publisher-id">PONE-D-16-46173</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Mathematical and statistical techniques</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (mathematics)</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and neoplasms</subject><subj-group><subject>Breast tumors</subject><subj-group><subject>Breast cancer</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancer risk factors</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and neoplasms</subject><subj-group><subject>Lung and intrathoracic tumors</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Population groupings</subject><subj-group><subject>Ethnicities</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Science policy</subject><subj-group><subject>Research integrity</subject><subj-group><subject>Publication ethics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Chromosome biology</subject><subj-group><subject>Chromosomes</subject><subj-group><subject>Chromosome structure and function</subject><subj-group><subject>Telomeres</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and neoplasms</subject><subj-group><subject>Hematologic cancers and related disorders</subject><subj-group><subject>Leukemias</subject><subj-group><subject>Myeloid leukemia</subject><subj-group><subject>Acute myeloid leukemia</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Hematology</subject><subj-group><subject>Hematologic cancers and related disorders</subject><subj-group><subject>Leukemias</subject><subj-group><subject>Myeloid leukemia</subject><subj-group><subject>Acute myeloid leukemia</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Association between TERT rs2853669 polymorphism and cancer risk: A meta-analysis of 9,157 cases and 11,073 controls</article-title>
<alt-title alt-title-type="running-head">TERT rs2853669 polymorphism and cancer risk</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9960-129X</contrib-id>
<name name-style="western">
<surname>Liu</surname>
<given-names>Zhengsheng</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Wang</surname>
<given-names>Tao</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Wu</surname>
<given-names>Zhun</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zhang</surname>
<given-names>Kaiyan</given-names>
</name>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Li</surname>
<given-names>Wei</given-names>
</name>
<role content-type="http://credit.casrai.org/">Software</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Yang</surname>
<given-names>Jianbin</given-names>
</name>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Chen</surname>
<given-names>Chenxi</given-names>
</name>
<role content-type="http://credit.casrai.org/">Software</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Chen</surname>
<given-names>Lei</given-names>
</name>
<role content-type="http://credit.casrai.org/">Software</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9704-889X</contrib-id>
<name name-style="western">
<surname>Xing</surname>
<given-names>Jinchun</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Urology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>The First Clinical Medical College of Fujian Medical University, Fuzhou, China</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Zhuxi People Hospital, Hubei, China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Liu</surname>
<given-names>Xuefeng</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Georgetown University, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">xmcua2007@sina.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>13</volume>
<issue>3</issue>
<elocation-id>e0191560</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>12</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>1</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-year>2018</copyright-year>
<copyright-holder>Liu et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0191560"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>It has been reported that the functional telomerase reverse transcriptase (TERT) rs2853669 polymorphism might contribute to different types of human cancer. However, the association of this mutation with cancer remains controversial. Here, we conducted a meta-analysis to characterize this relationship.</p>
</sec>
<sec id="sec002">
<title>Materials and methods/Main results</title>
<p>A systematic search of studies on the association of TERT rs2853669 polymorphism with all types of cancer was conducted in PubMed, Embase and Cochrane Library. The summary odds ratios (ORs) and corresponding 95% confidence intervals (95% CIs) were used to pool the effect size in a fixed-effects model or a random-effects model where appropriate. A total of 13 articles and 15 case-control studies, including 9,157 cases and 11,073 controls, were included in this meta-analysis. Overall, the pooled results indicated that the rs2853669 polymorphism was significantly associated with increased cancer risk in a homozygote comparison model (CT vs. TT: OR = 1.085, 95% CI: 1.015–1.159, P = 0.016). In the stratified analyses, a significant increased cancer risk was observed in Asian, but not Caucasian patients. A subgroup analysis by cancer type also revealed a significant increase in the risk of lung cancer, but not breast cancer.</p>
</sec>
<sec id="sec003">
<title>Conclusions</title>
<p>The results of this meta-analysis suggest that the TERT rs2853669 polymorphism is associated with a significantly increased risk of cancer, particularly lung cancer, in Asian populations.</p>
</sec>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100005270</institution-id>
<institution>Fujian Provincial Department of Science and Technology</institution>
</institution-wrap>
</funding-source>
<award-id>Nos.2016D009</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9704-889X</contrib-id>
<name name-style="western">
<surname>Xing</surname>
<given-names>Jinchun</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This work was supported by Fujian Provincial Department of Science and Technology (Grant No. 2016D009) and the Key Laboratory of Xiamen Urological Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="3"/>
<table-count count="2"/>
<page-count count="11"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec004" sec-type="intro">
<title>Introduction</title>
<p>Telomeres are stretches of conserved, tandemly repeated DNA sequences that form the physical ends of eukaryotic chromosomes [<xref ref-type="bibr" rid="pone.0191560.ref001">1</xref>]. Telomeres comprise long TTAGGG nucleotide repeats with a single-stranded overhang and protein complex [<xref ref-type="bibr" rid="pone.0191560.ref002">2</xref>], which plays an essential role in preserving genomic stability [<xref ref-type="bibr" rid="pone.0191560.ref003">3</xref>] and protecting linear chromosome ends [<xref ref-type="bibr" rid="pone.0191560.ref004">4</xref>]. Telomeres gradually decrease in length during cell division and eventually shorten below a critical threshold, thereby triggering senescence, apoptotic cell death, or genome instability [<xref ref-type="bibr" rid="pone.0191560.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0191560.ref006">6</xref>]. Telomerase, which adds a repeat DNA sequence to the end of telomeres, is a reverse transcriptase comprising an RNA molecule and a TERT protein [<xref ref-type="bibr" rid="pone.0191560.ref001">1</xref>, <xref ref-type="bibr" rid="pone.0191560.ref005">5</xref>]. TERT, a catalytic subunit of the enzyme telomerase, is critical for telomerase activity and has great importance in cancer progression. The activation of telomerase, which has been detected in nearly all human cancers, is a vital step in the progression of a majority of cancer types [<xref ref-type="bibr" rid="pone.0191560.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0191560.ref008">8</xref>].</p>
<p>Recently, many genome-wide association (GWA) studies focusing on cancer risk have been performed. TERT-locus single nucleotide polymorphisms (SNPs), located on chromosome 5p15.33, have reportedly been associated with the risk of several types of human cancers [<xref ref-type="bibr" rid="pone.0191560.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0191560.ref010">10</xref>]. A TERT promoter mutation (TERT-mut) creates a putative binding site for Ets/TCF transcription factors, increasing telomerase activity, whereas the TERT rs2853669 variant disrupts Ets/TCF binding [<xref ref-type="bibr" rid="pone.0191560.ref011">11</xref>]. The TERT rs2853669 T&gt;C polymorphism (SNP), located upstream of the TERT promoter region, has been shown to affect telomerase activity and telomere length [<xref ref-type="bibr" rid="pone.0191560.ref012">12</xref>].</p>
<p>The association between TERT rs2853669 and cancer risk has since been studied in multiple ethnicities and populations with inclusive results. Thus, we performed a meta-analysis screening of all relevant published data to clarify the association between the TERT rs2853669 polymorphism and cancer risk.</p>
</sec>
<sec id="sec005" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec006">
<title>2.1 Search strategy</title>
<p>Two independent investigators conducted a systematic published literature search in the PubMed, EMBASE, and Cochrane Library databases to identify studies evaluating the association between the TERT rs2853669 polymorphism and cancer risk conducted prior to October 14, 2016. The following keywords were used: “telomerase reverse transcriptase or TERT” and “cancer or tumor or carcinoma” and “polymorphism or polymorphisms or SNP or variants”. A search of all citations from the original studies was manually conducted to located further relevant studies.</p>
</sec>
<sec id="sec007">
<title>2.2 Inclusion and exclusion criteria</title>
<p>The inclusion criteria for studies in the current meta-analysis were as follows: (1) designed as a case-control study evaluating the association between the TERT rs2853669 polymorphism and cancer risk; (2) studied human tissues rather than animal tissues; (3) established definitive cancer diagnosis; and (4) contained available genotype frequency information to estimate the odds ratios (ORs) and 95% confidence intervals (95% CIs). The exclusion criteria were as follows: (1) duplication of same publications; (2) reviews, letters, posters and editorials; and (3) studies lacking detailed genotype frequencies.</p>
</sec>
<sec id="sec008">
<title>2.3 Data extraction</title>
<p>Two investigators independently extracted the usable data from the eligible studies, and a consensus was reached. In the case of a controversy, a consensus was reached through discussion. If the controversy remained, a third author would adjudicate the disagreements.</p>
<p>The following data were sought from each article: first author’s name, year of publication, country of origin, ethnicity (Caucasian, Asian and others), cancer type, source of control (hospital-based or population-based), number of cases and controls with CC, CT and CC genotypes, and Hardy Weinberg equilibrium. When Hardy Weinberg equilibrium (HWE) in the control genotype was not calculated, an online program (<ext-link ext-link-type="uri" xlink:href="http://ihg.gsf.de/cgi-bin/hw/hwa1.p" xlink:type="simple">http://ihg.gsf.de/cgi-bin/hw/hwa1.p</ext-link>) was used.</p>
</sec>
<sec id="sec009">
<title>2.4 Methodological quality assessment</title>
<p>Two researchers independently assessed the quality of the included studies according to the Newcastle-Ottawa Scale, of which the most significant factor was “age and gender”. The quality scores ranged from 0 to 9, and higher scores indicated better quality. The reviewers settled disagreements through discussion.</p>
</sec>
<sec id="sec010">
<title>2.5 Statistical analysis</title>
<p>This meta-analysis was performed according to the checklists and guidelines by PRISMA [<xref ref-type="bibr" rid="pone.0191560.ref013">13</xref>]. HWE was obtained for each study using the Chi-square test in the control groups, and P&lt;0.05 was considered a significant deviation from HWE. OR and 95% CIs were calculated to evaluate the strength of the association between the TERT rs2853669 polymorphism and susceptibility to cancer. Pooled ORs were computed from studies by allelic comparisons (C vs. T), dominant model (CC + CT vs. TT), recessive model (CC vs. CT + TT), homozygote comparisons (CC vs. TT) and heterozygote comparisons (CT vs. TT), respectively. The statistical significance level was based on a Z-test with P&lt; 0.05.</p>
<p>The heterogeneity in each study was evaluated based on Cochran’s Q statistic and the I<sup>2</sup> index. The random-effects model (DerSimonian and Laird method) was applied when P&lt;0.10 and/or I<sup>2</sup> index&gt;50%. Otherwise, if the heterogeneity test value was P&gt;0.10 and/or I<sup>2</sup> index&lt;50%, the fixed-effects model (Mantel and Haenszel method) was used. To evaluate the effect of each study on the combined ORs, a sensitivity analysis was conducted based on the leave-one-out method of each study in total and subgroups. In addition, subgroup analyses were stratified by cancer type (lung cancer, breast cancer, prostate cancer, gastric cancer, glioblastoma, colorectal cancer, acute myeloid leukemia [AML], and squamous cell carcinoma of the head and neck [SCCHN]), control type (population based and hospital based), and ethnicity (Caucasian, Asian, and others). Eventually, Begg's [<xref ref-type="bibr" rid="pone.0191560.ref014">14</xref>] funnel plot and Egger's [<xref ref-type="bibr" rid="pone.0191560.ref015">15</xref>] tests were used to statistically evaluate the publication bias. All statistical analyses were performed using Stata 12.0 software (StataCorp, College Station, Texas, USA). A two-tailed P&lt;0.05 was considered significant except for specified conditions, where a certain P value was declared.</p>
</sec>
</sec>
<sec id="sec011" sec-type="results">
<title>Results</title>
<sec id="sec012">
<title>3.1 Characteristics of the studies</title>
<p>A total of 925 articles were acquired from the databases (PubMed = 415, Embase = 502, Cochrane Library = 8), and thirteen articles met the inclusion criteria [<xref ref-type="bibr" rid="pone.0191560.ref016">16</xref>–<xref ref-type="bibr" rid="pone.0191560.ref028">28</xref>]. The detailed evaluation process is shown in <xref ref-type="fig" rid="pone.0191560.g001">Fig 1</xref>. Among the thirteen articles, two studies were conducted by Shadrina et al. [<xref ref-type="bibr" rid="pone.0191560.ref023">23</xref>] and Varadi et al. [<xref ref-type="bibr" rid="pone.0191560.ref025">25</xref>]. In total, fifteen case-control studies were enrolled, including 9,157 cases and 11,073 controls, to explore the relationship between the TERT rs2853669 polymorphism and cancer risk. The characteristics of the studies are shown in <xref ref-type="table" rid="pone.0191560.t001">Table 1</xref>. Different genotyping methods were utilized, including Taqman, LightCycler (a method of real-time polymerase chain reaction), and sequencing. Blood samples were used for genotyping in all studies. Among all fifteen studies, 5 studies focused on breast cancer [<xref ref-type="bibr" rid="pone.0191560.ref021">21</xref>–<xref ref-type="bibr" rid="pone.0191560.ref025">25</xref>], three studies focused on lung cancer [<xref ref-type="bibr" rid="pone.0191560.ref026">26</xref>–<xref ref-type="bibr" rid="pone.0191560.ref028">28</xref>], and one study each focused on gastric cancer [<xref ref-type="bibr" rid="pone.0191560.ref016">16</xref>], prostate cancer [<xref ref-type="bibr" rid="pone.0191560.ref023">23</xref>], AML [<xref ref-type="bibr" rid="pone.0191560.ref020">20</xref>], glioblastoma [<xref ref-type="bibr" rid="pone.0191560.ref019">19</xref>], colorectal cancer [<xref ref-type="bibr" rid="pone.0191560.ref017">17</xref>] and SCCHN [<xref ref-type="bibr" rid="pone.0191560.ref018">18</xref>]. The cancer types were also definitively confirmed through histological or pathological analyses among all studies. Among the 15 included studies, 11 studies included Caucasian descents, three studies included Asian descents and one study included 94% Caucasian, 4% African-American and 2% other descents. The control sources were population based in 7 studies and hospital based in 8 studies.</p>
<fig id="pone.0191560.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0191560.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Flow chart of study selection.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0191560.g001" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0191560.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0191560.t001</object-id>
<label>Table 1</label> <caption><title>Characteristics of the studies included in the meta-analysis.</title></caption>
<alternatives>
<graphic id="pone.0191560.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0191560.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" rowspan="2">NO.</th>
<th align="justify" rowspan="2">Study ID</th>
<th align="justify" rowspan="2">Year</th>
<th align="justify" rowspan="2">Country</th>
<th align="justify" rowspan="2">Ethnicity</th>
<th align="justify" rowspan="2">Cancer Type</th>
<th align="left" rowspan="2">Control Type</th>
<th align="justify" rowspan="2">Cases</th>
<th align="justify" rowspan="2">Controls</th>
<th align="justify" colspan="3">Case</th>
<th align="justify" colspan="3">Controls</th>
<th align="justify" rowspan="2">HWE<xref ref-type="table-fn" rid="t001fn001"><sup>#</sup></xref></th>
<th align="center" rowspan="2">Quality<xref ref-type="table-fn" rid="t001fn001"><sup>#</sup></xref></th>
</tr>
<tr>
<th align="justify">CC</th>
<th align="justify">CT</th>
<th align="justify">TT</th>
<th align="justify">CC</th>
<th align="justify">CT</th>
<th align="justify">TT</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center">1</td>
<td align="justify">Xing et al.</td>
<td align="justify">2016</td>
<td align="justify">China</td>
<td align="justify">Asian</td>
<td align="justify">Lung Cancer</td>
<td align="justify">HB<xref ref-type="table-fn" rid="t001fn005">*</xref></td>
<td align="justify">418</td>
<td align="justify">410</td>
<td align="justify">41</td>
<td align="justify">162</td>
<td align="justify">215</td>
<td align="justify">30</td>
<td align="justify">145</td>
<td align="justify">235</td>
<td align="char" char=".">0.249</td>
<td align="center">7</td>
</tr>
<tr>
<td align="center">2</td>
<td align="justify">Oztas et al.</td>
<td align="justify">2016</td>
<td align="justify">Turkey</td>
<td align="justify">Caucasian</td>
<td align="justify">Breast Cancer</td>
<td align="justify">HB</td>
<td align="justify">107</td>
<td align="justify">110</td>
<td align="justify">24</td>
<td align="justify">47</td>
<td align="justify">36</td>
<td align="justify">25</td>
<td align="justify">52</td>
<td align="justify">31</td>
<td align="char" char=".">0.723</td>
<td align="center">7</td>
</tr>
<tr>
<td align="center">3</td>
<td align="justify">Bayram et al.</td>
<td align="justify">2016</td>
<td align="justify">Turkey</td>
<td align="justify">Caucasian</td>
<td align="justify">Gastric Cancer</td>
<td align="justify">HB</td>
<td align="justify">104</td>
<td align="justify">209</td>
<td align="justify">13</td>
<td align="justify">47</td>
<td align="justify">44</td>
<td align="justify">35</td>
<td align="justify">99</td>
<td align="justify">75</td>
<td align="char" char=".">0.810</td>
<td align="center">8</td>
</tr>
<tr>
<td align="center">4</td>
<td align="justify">Yoo et al.</td>
<td align="justify">2015</td>
<td align="justify">Korea</td>
<td align="justify">Asian</td>
<td align="justify">Lung Cancer</td>
<td align="justify">HB</td>
<td align="justify">1100</td>
<td align="justify">1096</td>
<td align="justify">137</td>
<td align="justify">477</td>
<td align="justify">478</td>
<td align="justify">105</td>
<td align="justify">490</td>
<td align="justify">485</td>
<td align="char" char=".">0.242</td>
<td align="center">8</td>
</tr>
<tr>
<td align="center">5</td>
<td align="justify">Shadrina et al.1</td>
<td align="justify">2014</td>
<td align="justify">Russian</td>
<td align="justify">Caucasian</td>
<td align="justify">Breast Cancer</td>
<td align="justify">HB</td>
<td align="justify">659</td>
<td align="justify">522</td>
<td align="justify">63</td>
<td align="justify">225</td>
<td align="justify">371</td>
<td align="justify">42</td>
<td align="justify">195</td>
<td align="justify">285</td>
<td align="char" char=".">0.291</td>
<td align="center">6</td>
</tr>
<tr>
<td align="center">6</td>
<td align="justify">Shadrina et al.2</td>
<td align="justify">2014</td>
<td align="justify">Russian</td>
<td align="justify">Caucasian</td>
<td align="justify">Prostate Cancer</td>
<td align="justify">HB</td>
<td align="justify">372</td>
<td align="justify">363</td>
<td align="justify">36</td>
<td align="justify">169</td>
<td align="justify">167</td>
<td align="justify">30</td>
<td align="justify">127</td>
<td align="justify">206</td>
<td align="char" char=".">0.104</td>
<td align="center">6</td>
</tr>
<tr>
<td align="center">7</td>
<td align="justify">Mosrati et al.</td>
<td align="justify">2015</td>
<td align="justify">Sweden</td>
<td align="justify">Caucasian</td>
<td align="justify">AML<xref ref-type="table-fn" rid="t001fn001"><sup>#</sup></xref></td>
<td align="justify">PB<xref ref-type="table-fn" rid="t001fn005">*</xref></td>
<td align="justify">226</td>
<td align="justify">779</td>
<td align="justify">38</td>
<td align="justify">99</td>
<td align="justify">89</td>
<td align="justify">65</td>
<td align="justify">341</td>
<td align="justify">373</td>
<td align="char" char=".">0.293</td>
<td align="center">5</td>
</tr>
<tr>
<td align="center">8</td>
<td align="justify">Mosrati et al.</td>
<td align="justify">2015</td>
<td align="justify">Sweden</td>
<td align="justify">Caucasian</td>
<td align="justify">Glioblastoma</td>
<td align="justify">PB</td>
<td align="justify">128</td>
<td align="justify">779</td>
<td align="justify">11</td>
<td align="justify">48</td>
<td align="justify">69</td>
<td align="justify">65</td>
<td align="justify">341</td>
<td align="justify">373</td>
<td align="char" char=".">0.293</td>
<td align="center">5</td>
</tr>
<tr>
<td align="center">9</td>
<td align="justify">Jannuzzi et al.</td>
<td align="justify">2015</td>
<td align="justify">Turkey</td>
<td align="justify">Caucasian</td>
<td align="justify">Colorectal Cancer</td>
<td align="justify">HB</td>
<td align="justify">104</td>
<td align="justify">135</td>
<td align="justify">15</td>
<td align="justify">50</td>
<td align="justify">31</td>
<td align="justify">17</td>
<td align="justify">58</td>
<td align="justify">40</td>
<td align="char" char=".">0.586</td>
<td align="center">8</td>
</tr>
<tr>
<td align="center">10</td>
<td align="justify">Zhong et al.</td>
<td align="justify">2013</td>
<td align="justify">China</td>
<td align="justify">Asian</td>
<td align="justify">Lung Cancer</td>
<td align="justify">PB</td>
<td align="justify">498</td>
<td align="justify">502</td>
<td align="justify">108</td>
<td align="justify">242</td>
<td align="justify">148</td>
<td align="justify">72</td>
<td align="justify">224</td>
<td align="justify">206</td>
<td align="char" char=".">0.381</td>
<td align="center">8</td>
</tr>
<tr>
<td align="center">11</td>
<td align="justify">Liu et al.</td>
<td align="justify">2011</td>
<td align="justify">USA</td>
<td align="justify">Caucasian</td>
<td align="justify">SCCHN<xref ref-type="table-fn" rid="t001fn001"><sup>#</sup></xref></td>
<td align="justify">HB</td>
<td align="justify">888</td>
<td align="justify">885</td>
<td align="justify">79</td>
<td align="justify">381</td>
<td align="justify">428</td>
<td align="justify">85</td>
<td align="justify">375</td>
<td align="justify">425</td>
<td align="char" char=".">0.863</td>
<td align="center">7</td>
</tr>
<tr>
<td align="center">12</td>
<td align="justify">Jing Shen al. <xref ref-type="table-fn" rid="t001fn006">**</xref></td>
<td align="justify">2010</td>
<td align="justify">USA</td>
<td align="justify">Other<xref ref-type="table-fn" rid="t001fn007">***</xref></td>
<td align="justify">Breast Cancer</td>
<td align="justify">PB</td>
<td align="justify">1034</td>
<td align="justify">1082</td>
<td align="justify">86</td>
<td align="justify">445</td>
<td align="justify">503</td>
<td align="justify">128</td>
<td align="justify">432</td>
<td align="justify">522</td>
<td align="char" char=".">0.009</td>
<td align="center">8</td>
</tr>
<tr>
<td align="center">13</td>
<td align="justify">Varadi et al.1</td>
<td align="justify">2008</td>
<td align="justify">Poland</td>
<td align="justify">Caucasian</td>
<td align="justify">Breast Cancer</td>
<td align="justify">PB</td>
<td align="justify">768</td>
<td align="justify">400</td>
<td align="justify">58</td>
<td align="justify">299</td>
<td align="justify">411</td>
<td align="justify">38</td>
<td align="justify">154</td>
<td align="justify">244</td>
<td align="char" char=".">0.059</td>
<td align="center">7</td>
</tr>
<tr>
<td align="center">14</td>
<td align="justify">Varadi et al.2<xref ref-type="table-fn" rid="t001fn006">**</xref></td>
<td align="justify">2008</td>
<td align="justify">Sweden</td>
<td align="justify">Caucasian</td>
<td align="justify">Breast Cancer</td>
<td align="justify">PB</td>
<td align="justify">766</td>
<td align="justify">1519</td>
<td align="justify">47</td>
<td align="justify">310</td>
<td align="justify">409</td>
<td align="justify">143</td>
<td align="justify">558</td>
<td align="justify">818</td>
<td align="char" char=".">0.001</td>
<td align="center">7</td>
</tr>
<tr>
<td align="center">15</td>
<td align="justify">Savage et al.</td>
<td align="justify">2007</td>
<td align="justify">Poland</td>
<td align="justify">Caucasian</td>
<td align="justify">Breast Cancer</td>
<td align="justify">PB</td>
<td align="justify">1985</td>
<td align="justify">2282</td>
<td align="justify">1095</td>
<td align="justify">766</td>
<td align="justify">124</td>
<td align="justify">1224</td>
<td align="justify">900</td>
<td align="justify">158</td>
<td align="char" char=".">0.669</td>
<td align="center">8</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p><sup>#</sup>: Quality was evaluated according to NOS, and the most important factor was “age and gender”.</p></fn>
<fn id="t001fn002"><p>AML: acute myeloid leukemia</p></fn>
<fn id="t001fn003"><p>SCCHN: squamous cell carcinoma of the head and neck</p></fn>
<fn id="t001fn004"><p>HWE: Hardy-Weinberg equilibrium, P&lt; 0.05 was considered as a significant departure from HWE;</p></fn>
<fn id="t001fn005"><p>*PB: population-based; HB: hospital-based.</p></fn>
<fn id="t001fn006"><p>**P for HWE&lt; 0.05 in controls who are all women.</p></fn>
<fn id="t001fn007"><p>***Other: 94% Caucasian, 4% African American and 2% other descent</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec013">
<title>3.2 Main meta-analysis results</title>
<p>According to all eligible studies, the results indicated a statistically significant association between the TERT rs2853669 polymorphism and cancer susceptibility in the homozygote comparison (CT vs. TT: OR = 1.085, 95% CI = 1.015–1.159; P = 0.016, <xref ref-type="fig" rid="pone.0191560.g002">Fig 2</xref>.) (fixed-effects model). Therefore, an association of homozygote CT with increased risk of cancer was confirmed. However, no significance was observed in the other four genetic models, including in the allele model (C vs. T: OR = 1.071, 95% CI = 0.984–1.165, P = 0.113), the homozygote comparison model (CC vs. TT: OR = 1.114, 95% CI: 0.906–1.369; P = 0.307), recessive model (CC vs. CT+TT: OR = 1.070, 95% CI = 0.903–1.268; P = 0.436) and dominant model (CT+CC vs. TT: OR = 1.098, 95% CI = 0.992–1.214; P = 0.070), whereas a trend of increased risk was observed. The results of each genetic model are shown in <xref ref-type="table" rid="pone.0191560.t002">Table 2</xref>.</p>
<fig id="pone.0191560.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0191560.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Forest plot of homozygote comparison (CT versus TT) for overall comparison, using a fixed-effects model.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0191560.g002" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0191560.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0191560.t002</object-id>
<label>Table 2</label> <caption><title>Summary of pooled ORs in the stratified analysis association between TERT rs2853669 and cancer risk.</title></caption>
<alternatives>
<graphic id="pone.0191560.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0191560.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify" rowspan="2">Variables</th>
<th align="justify" rowspan="2">Case/control</th>
<th align="justify" colspan="2">C versus T</th>
<th align="justify" colspan="2">CT versus TT</th>
<th align="justify" colspan="2">CC versus TT</th>
<th align="justify" colspan="2">CT+CC versus TT</th>
<th align="justify" colspan="2">CC versus CT+TT</th>
</tr>
<tr>
<th align="justify">OR<xref ref-type="table-fn" rid="t002fn001">*</xref>(95% CI<xref ref-type="table-fn" rid="t002fn001">*</xref>)</th>
<th align="center">I <sup>2</sup> (%)</th>
<th align="justify">OR (95% CI)</th>
<th align="center">I <sup>2</sup> (%)</th>
<th align="justify">OR (95% CI)</th>
<th align="center">I <sup>2</sup> (%)</th>
<th align="justify">OR (95% CI)</th>
<th align="center">I <sup>2</sup> (%)</th>
<th align="justify">OR (95% CI)</th>
<th align="center">I <sup>2</sup> (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify">Total</td>
<td align="justify">9157/11073</td>
<td align="justify">1.071(0.984–1.165)</td>
<td align="center"><bold>68.1</bold></td>
<td align="justify"><bold>1.085(1.015–1.159)</bold></td>
<td align="center">39.9</td>
<td align="justify">1.114(0.906–1.369)</td>
<td align="char" char="."><bold>71.9</bold></td>
<td align="justify">1.098(0.992–1.214)</td>
<td align="center"><bold>55.6</bold></td>
<td align="justify">1.070(0.903–1.268)</td>
<td align="center"><bold>68.4</bold></td>
</tr>
<tr>
<td align="justify">Cancer type</td>
<td align="justify"/>
<td align="justify"/>
<td align="center"/>
<td align="justify"/>
<td align="center"/>
<td align="justify"/>
<td align="center"/>
<td align="justify"/>
<td align="center"/>
<td align="justify"/>
<td align="center"/>
</tr>
<tr>
<td align="justify">Breast cancer</td>
<td align="justify">5319/5915</td>
<td align="justify">0.989(0.932–1.050)</td>
<td align="center">0</td>
<td align="justify">1.056(0.961–1.161)</td>
<td align="center">0</td>
<td align="justify">0.880(0.703–1.102)</td>
<td align="char" char="."><bold>53.4</bold></td>
<td align="justify">1.014(0.927–1.109)</td>
<td align="center">0</td>
<td align="justify">0.872(0.691–1.100)</td>
<td align="center"><bold>68.4</bold></td>
</tr>
<tr>
<td align="justify">Lung cancer</td>
<td align="justify">2016/2008</td>
<td align="justify"><bold>1.248(1.035–1.505)</bold></td>
<td align="center"><bold>71.9</bold></td>
<td align="justify">1.198(0.927–1.548)</td>
<td align="center"><bold>69.2</bold></td>
<td align="justify"><bold>1.558(1.270–1.912)</bold></td>
<td align="char" char=".">46.8</td>
<td align="justify">1.280(0.975–1.681)</td>
<td align="center"><bold>75.7</bold></td>
<td align="justify"><bold>1.442(1.190–1.747)</bold></td>
<td align="center">0</td>
</tr>
<tr>
<td align="justify">Others</td>
<td align="justify">1822/3150</td>
<td align="justify">1.083(0.891–1.317)</td>
<td align="center"><bold>73.2</bold></td>
<td align="justify">1.080(0.862–1.354)</td>
<td align="center"><bold>59.4</bold></td>
<td align="justify">1.180(0.789–1.764)</td>
<td align="char" char="."><bold>68.1</bold></td>
<td align="justify">1.096(0.861–1.396)</td>
<td align="center"><bold>68.2</bold></td>
<td align="justify">1.146(0.811–1.617)</td>
<td align="center"><bold>61.2</bold></td>
</tr>
<tr>
<td align="justify" colspan="2">Source of control</td>
<td align="justify"/>
<td align="center"/>
<td align="justify"/>
<td align="center"/>
<td align="justify"/>
<td align="center"/>
<td align="justify"/>
<td align="center"/>
<td align="justify"/>
<td align="center"/>
</tr>
<tr>
<td align="justify">Population based</td>
<td align="justify">5405/7343</td>
<td align="justify">1.080(0.940–1.242)</td>
<td align="center"><bold>80.9</bold></td>
<td align="justify"><bold>1.124(1.026–1.230)</bold></td>
<td align="center">30.0</td>
<td align="justify">1.116(0.770–1.618)</td>
<td align="char" char="."><bold>85.5</bold></td>
<td align="justify">1.125(0.966–1.310)</td>
<td align="center"><bold>65.2</bold></td>
<td align="justify">1.046(0.777–1.407)</td>
<td align="center"><bold>84.0</bold></td>
</tr>
<tr>
<td align="justify">Hospital based</td>
<td align="justify">3752/3730</td>
<td align="justify">1.066(0.994–1.143)</td>
<td align="center">43.7</td>
<td align="justify">1.042(0.945–1.148)</td>
<td align="center"><bold>48.1</bold></td>
<td align="justify">1.149(0.981–1.346)</td>
<td align="char" char=".">10.3</td>
<td align="justify">1.065(0.971–1.167)</td>
<td align="center">50.0</td>
<td align="justify">1.134(0.976–1.318)</td>
<td align="center">0</td>
</tr>
<tr>
<td align="justify">Ethnicity</td>
<td align="justify"/>
<td align="justify"/>
<td align="center"/>
<td align="justify"/>
<td align="center"/>
<td align="justify"/>
<td align="center"/>
<td align="justify"/>
<td align="center"/>
<td align="justify"/>
<td align="center"/>
</tr>
<tr>
<td align="justify">Caucasian</td>
<td align="justify">6107/7983</td>
<td align="justify">1.040(0.948–1.140)</td>
<td align="center"><bold>56.7</bold></td>
<td align="justify">1.068(0.981–1.162)</td>
<td align="center">38.2</td>
<td align="justify">1.048(0.838–1.312)</td>
<td align="char" char="."><bold>60.7</bold></td>
<td align="justify">1.060(0.978–1.148)</td>
<td align="center">46.8</td>
<td align="justify">1.024(0.848–1.237)</td>
<td align="center"><bold>57.9</bold></td>
</tr>
<tr>
<td align="justify">Asian</td>
<td align="justify">2016/2008</td>
<td align="justify"><bold>1.248(1.035–1.505)</bold></td>
<td align="center"><bold>71.9</bold></td>
<td align="justify">1.198(0.927–1.548)</td>
<td align="center"><bold>69.2</bold></td>
<td align="justify"><bold>1.558(1.270–1.912)</bold></td>
<td align="char" char=".">46.8</td>
<td align="justify">1.280(0.975–1.681)</td>
<td align="center"><bold>75.7</bold></td>
<td align="justify"><bold>1.442(1.190–1.747)</bold></td>
<td align="center">0</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>*PB = Population-based, HB = Hospital-based. OR = Odds ratio, CI = Confidence interval. Results with a positive significant difference are indicated in bold.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Sub-group analyses were performed to investigate the effect of cancer types, source of control and ethnicity. For cancer types, increased cancer risk was demonstrated in lung cancer in the allelic comparison (C vs. T:OR = 1.248, 95% CI = 1.035–1.505; P = 0.020), homozygote comparison (CC vs. TT: OR = 1.558, 95% CI = 1.270–1.912; P = 0.000) and recessive model (CC vs. CT+TT: OR = 1.442, 95% CI = 1.190–1.747; P = 0.000). However, no significant difference was observed in breast cancer in any genetic model (detailed in <xref ref-type="table" rid="pone.0191560.t002">Table 2</xref>).</p>
<p>When stratifying according to ethnicity, greatly affected cancer susceptibility associations between the TERT rs2853669 polymorphism and cancer susceptibility were observed in Asians in the allelic comparison (C vs. T: OR = 1.248, 95% CI = 1.035–1.505; P = 0.020), homozygote comparison (CC vs. TT: OR = 1.590, 95% CI = 1.183–2.135; P = 0.000) and recessive model (CC vs. CT + TT: OR = 1.442, 95% CI = 1.190–1.746; P = 0.000), but not for Caucasians in any of the genetic models. For source of control, however, only one homozygote comparison (CT vs. TT: OR = 1.124, 95% CI = 1.026–1.230; P = 0.012) in the population-based control source showed a significant association between the TERT rs2853669 polymorphism and cancer risk.</p>
</sec>
<sec id="sec014">
<title>3.3 Heterogeneity</title>
<p>As shown in <xref ref-type="table" rid="pone.0191560.t002">Table 2</xref>, heterogeneity was observed between studies in the four genetic comparisons. Significant heterogeneity existed in the allele model (C vs. T:OR = 1.071, 95% CI = 0.984–1.165, P = 0.113), homozygote comparison model (CC vs. TT: OR = 1.114, 95% CI: 0.906–1.369; P = 0.307), recessive model (CC vs. CT+TT: OR = 1.070, 95% CI = 0.903–1.268; P<sub>heterogeneity</sub> = 0.007) and dominant model (CT+CC versus TT: OR = 1.098, 95% CI = 0.992–1.214; P<sub>heterogeneity</sub> = 0.005). However, when stratified based on subgroup analysis, heterogeneity disappeared in breast cancer, which was stratified into cancer type and hospital-based control source subgroups.</p>
<p>Meta-regression was also used to examine the source of heterogeneity based on cancer types, source of control and ethnicity in the variant heterozygote comparison (CC vs. TT). The results indicated that ethnicity (P<sub>heterogeneity</sub> = 0.02) contributed to the source of heterogeneity, but not cancer types (P<sub>heterogeneity</sub> = 0.15) or source of control (P<sub>heterogeneity</sub> = 0.23). Consequently, ethnicity explained 44.67% of the between studies variance.</p>
</sec>
<sec id="sec015">
<title>3.4 Sensitivity analyses</title>
<p>Sensitivity analysis was performed to evaluate the influence of the single studies on the pooled ORs based on the sequential removal of individual included studies each time. Subsequently, the results further demonstrated that no individual study significantly affected the pooled OR, thus, the overall results indicated the stability and reliability (not shown in figure).</p>
</sec>
<sec id="sec016">
<title>3.5 Publication bias</title>
<p>Begg’s funnel plot and Egger’s test were used to estimate the publication bias of eligible studies. No publication bias for the association between TERT rs2853669 polymorphism and cancer susceptibility was manifested based on Begg’s funnel plot (P<sub>Begg</sub> = 0.921, CC versus TT, <xref ref-type="fig" rid="pone.0191560.g003">Fig 3</xref>) or Egger’s regression test (P<sub>Egger</sub> = 0.652, CC versus TT). Similarly, these results still did not show publication bias under the other genetic models (C vs. T P<sub>Begg</sub> = 0.692, CT+CC vs. TT P<sub>Begg</sub> = 0.843, CT vs. TT P<sub>Begg</sub> = 0.767 and CC vs. CT + TT; P<sub>Begg</sub> = 0.843). Consequently, there was no the evidence of publication bias in our meta-analysis.</p>
<fig id="pone.0191560.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0191560.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Begg’s funnel plot for publication bias analysis association between the TERT rs2853669 polymorphism and cancer risk (CT vs. TT).</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0191560.g003" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec017" sec-type="conclusions">
<title>Discussion</title>
<p>Telomeres are structural elements that protect the ends of chromosomes from degradation, end-to-end fusion, recognition as damaged DNA and maintenance of chromosomal stability [<xref ref-type="bibr" rid="pone.0191560.ref029">29</xref>, <xref ref-type="bibr" rid="pone.0191560.ref030">30</xref>]. TERT, encoded by the TERT gene, is an essential component of telomerase that plays a crucial role in enzymatic activity in human telomerase [<xref ref-type="bibr" rid="pone.0191560.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0191560.ref032">32</xref>]. The reactivation of telomerase drives human cell immortality, which is critical in human cancer, reflecting the fact that most cancers involve high levels of telomerase activity [<xref ref-type="bibr" rid="pone.0191560.ref033">33</xref>–<xref ref-type="bibr" rid="pone.0191560.ref035">35</xref>].</p>
<p>The promoter region of TERT, located at positions c.-124:C&gt;T and c.-146:C&gt;T, is considered a regulatory element for telomerase activity, which regulates gene transcription through several binding sites for factors [<xref ref-type="bibr" rid="pone.0191560.ref035">35</xref>, <xref ref-type="bibr" rid="pone.0191560.ref036">36</xref>]. Moreover, the TERT promoter creates a putative binding site for Ets/TCF transcription factors to enhance telomerase expression and activity. The rs2853669 variant, a novel single nucleotide polymorphism (SNP) -245 kb upstream (Ets2 binding site) of the TERT gene, prevents Ets/TCF binding [<xref ref-type="bibr" rid="pone.0191560.ref037">37</xref>, <xref ref-type="bibr" rid="pone.0191560.ref038">38</xref>] [<xref ref-type="bibr" rid="pone.0191560.ref039">39</xref>]. A recent study suggested that a functional promoter polymorphism, TERT rs2853669, may influence both telomere length and telomerase activity [<xref ref-type="bibr" rid="pone.0191560.ref027">27</xref>, <xref ref-type="bibr" rid="pone.0191560.ref040">40</xref>]. Thus, TERT rs2853669 is strongly associated with the promoter region of telomerase reverse transcriptase. A growing number of epidemiological studies have been conducted to determine the associations between this polymorphism and cancer risk, particularly for breast cancer and lung cancer; however, the results were inconclusive.</p>
<p>In the present meta-analysis, 9,157 cases and 11,073 controls extracted from thirteen eligible studies were analyzed and evaluated. Significant statistics were observed for the association between the TERT rs2853669 polymorphism and cancer susceptibility in the variant CT homozygote compared with the TT wild-type homozygote model. Furthermore, three genetic models, the allelic model (C vs. T), homozygote model (CC vs. TT) and recessive model (CC vs. CT + TT), also demonstrated a strong association of increasing lung cancer susceptibility in Asian populations. Notably, no significant increasing risk of breast cancer was observed in our meta-analysis.</p>
<p>As shown in our meta-analysis, significant statistical heterogeneity was observed. Meta-regression was also used to detect the origin of this heterogeneity, showing that the ethnicity was the source of heterogeneity. However, when the stratification was based on subgroup analysis, heterogeneity disappeared in breast cancer, which stratified in the cancer type subgroup and hospital-based source control subgroup. Therefore, there is a strong foundation to consider between the etiology of different tumors and source of control groups, which also contributed to the source of heterogeneity. The results of the sensitivity analysis were reliable and robust. Additionally, neither the shape of the funnel plots nor the publication bias results showed statistical significance in this meta-analysis.</p>
<p>Surprisingly, during the subgroup analysis stratified by cancer type, no significant increase in the risk of breast cancer was observed in any genetic model. However, our result is contrary to that of Li et al. [<xref ref-type="bibr" rid="pone.0191560.ref041">41</xref>], who concluded that TERT rs2853669 polymorphisms were associated with the increased risk of developing breast cancer (OR = 0.76; 95% CI: 0.63–0.90; P = 0.002). Subsequently, two investigators carefully assessed the results of the meta-analysis, and a marked difference between the Li et al study and our meta-analysis was observed when studies NO.2 and NO.5 were included. When focused on lung cancer, a significant increase cancer risk was observed in association with this polymorphism. Increasing cancer susceptibility was observed in Asians, but not for Caucasians, when stratified by ethnicity. Consistently, three lung cancer studies [<xref ref-type="bibr" rid="pone.0191560.ref026">26</xref>–<xref ref-type="bibr" rid="pone.0191560.ref028">28</xref>] were conducted in Asians, thus an increased risk was observed in the allelic comparison (C vs. T), homozygote comparison (CC vs. TT) and recessive model (CC vs. CT+TT). This finding suggests that different populations might have different tumorigenesis mechanisms. Similarly, in the subgroup analysis stratified by source of control, significant associations were observed in the population-based studies, but not in the hospital-based studies.</p>
<p>In addition, the potential limitations of our meta-analysis should also be addressed. First, insufficient published studies were included in this meta-analysis, and more individual studies were required to determine a precise conclusion. Second, the results of gene-to-environment interactions were not obtained because of a lack of relevant information. Third, studies NO.12 and NO.14 did not meet the expectations of Hardy-Weinberg equilibrium, as both studies were focused on breast cancer. Fourth, in our meta-analysis, one cancer type (lung cancer or breast cancer) was only focused on one ethnicity (Asian or Caucasian). Therefore, additional high-level studies on different ethnicities are still needed.</p>
</sec>
<sec id="sec018" sec-type="conclusions">
<title>Conclusions</title>
<p>In conclusion, this meta-analysis suggests that the TERT genetic polymorphism rs2853669 is associated with an increased risk of cancer, particularly for lung cancer among Asians, while there is no significant association with increased risk of breast cancer. However, more functional studies with additional subgroups should be conducted to validate our findings.</p>
</sec>
<sec id="sec019">
<title>Supporting information</title>
<supplementary-material id="pone.0191560.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0191560.s001" xlink:type="simple">
<label>S1 File</label>
<caption>
<title>Meta-analysis on genetic association studies checklist.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0191560.s002" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0191560.s002" xlink:type="simple">
<label>S2 File</label>
<caption>
<title>PRISMA checklist.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We thank Dr. Qin Jiaxuan and Dr. Long-cheng Li for providing guidance in this work. This work was supported by Fujian Provincial Department of Science and Technology (Grant No. 2016D009) and the Key Laboratory of Xiamen Urological Center.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0191560.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Giardini</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Segatto</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>da Silva</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Nunes</surname> <given-names>VS</given-names></name>, <name name-style="western"><surname>Cano</surname> <given-names>MI</given-names></name>. <article-title>Telomere and telomerase biology</article-title>. <source>Prog Mol Biol Transl Sci</source>. <year>2014</year>;<volume>125</volume>:<fpage>1</fpage>–<lpage>40</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/B978-0-12-397898-1.00001-3" xlink:type="simple">10.1016/B978-0-12-397898-1.00001-3</ext-link></comment> <object-id pub-id-type="pmid">24993696</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mirabello</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kraft</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>De Vivo</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Hunter</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Prescott</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>The association of telomere length and genetic variation in telomere biology genes</article-title>. <source>Human mutation</source>. <year>2010</year>;<volume>31</volume>(<issue>9</issue>):<fpage>1050</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/humu.21314" xlink:type="simple">10.1002/humu.21314</ext-link></comment> <object-id pub-id-type="pmid">20597107</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Karami</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Han</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Pande</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Cheng</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Rudd</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Pierce</surname> <given-names>BL</given-names></name>, <etal>et al</etal>. <article-title>Telomere structure and maintenance gene variants and risk of five cancer types</article-title>. <source>International journal of cancer</source>. <year>2016</year>;<volume>139</volume>(<issue>12</issue>):<fpage>2655</fpage>–<lpage>70</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ijc.30288" xlink:type="simple">10.1002/ijc.30288</ext-link></comment> <object-id pub-id-type="pmid">27459707</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Opresko</surname> <given-names>PL</given-names></name>, <name name-style="western"><surname>Shay</surname> <given-names>JW</given-names></name>. <article-title>Telomere-associated aging disorders</article-title>. <source>Ageing Res Rev</source>. <year>2016</year>. Epub 2016/05/25. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.arr.2016.05.009" xlink:type="simple">10.1016/j.arr.2016.05.009</ext-link></comment> <object-id pub-id-type="pmid">27215853</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bianchi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Shore</surname> <given-names>D</given-names></name>. <article-title>How telomerase reaches its end: mechanism of telomerase regulation by the telomeric complex</article-title>. <source>Molecular cell</source>. <year>2008</year>;<volume>31</volume>(<issue>2</issue>):<fpage>153</fpage>–<lpage>65</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2008.06.013" xlink:type="simple">10.1016/j.molcel.2008.06.013</ext-link></comment> <object-id pub-id-type="pmid">18657499</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Counter</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Avilion</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>LeFeuvre</surname> <given-names>CE</given-names></name>, <name name-style="western"><surname>Stewart</surname> <given-names>NG</given-names></name>, <name name-style="western"><surname>Greider</surname> <given-names>CW</given-names></name>, <name name-style="western"><surname>Harley</surname> <given-names>CB</given-names></name>, <etal>et al</etal>. <article-title>Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity</article-title>. <source>The EMBO journal</source>. <year>1992</year>;<volume>11</volume>(<issue>5</issue>):<fpage>1921</fpage>. <object-id pub-id-type="pmid">1582420</object-id></mixed-citation></ref>
<ref id="pone.0191560.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Akincilar</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Unal</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Tergaonkar</surname> <given-names>V</given-names></name>. <article-title>Reactivation of telomerase in cancer</article-title>. <source>Cell Mol Life Sci</source>. <year>2016</year>;<volume>73</volume>(<issue>8</issue>):<fpage>1659</fpage>–<lpage>70</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00018-016-2146-9" xlink:type="simple">10.1007/s00018-016-2146-9</ext-link></comment> <object-id pub-id-type="pmid">26846696</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kumar</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Lechel</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Gunes</surname> <given-names>C</given-names></name>. <article-title>Telomerase: The Devil Inside</article-title>. <source>Genes</source>. <year>2016</year>;<volume>7</volume>(<issue>8</issue>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/genes7080043" xlink:type="simple">10.3390/genes7080043</ext-link></comment> <object-id pub-id-type="pmid">27483324</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kachuri</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Latifovic</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Hung</surname> <given-names>RJ</given-names></name>. <article-title>Systematic review of genetic variation in chromosome 5p15.33 and telomere length as predictive and prognostic biomarkers for lung cancer</article-title>. <source>Cancer epidemiology, biomarkers &amp; prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</source>. <year>2016</year>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/1055-9965.EPI-16-0200" xlink:type="simple">10.1158/1055-9965.EPI-16-0200</ext-link></comment> <object-id pub-id-type="pmid">27566420</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Petersen</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Risch</surname> <given-names>HA</given-names></name>, <name name-style="western"><surname>Klein</surname> <given-names>AP</given-names></name>, <name name-style="western"><surname>Killedar</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Stutz</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Sobinoff</surname> <given-names>AP</given-names></name>, <etal>et al</etal>. <article-title>A Common Cancer Risk-Associated Allele in the hTERT Locus Encodes a Dominant Negative Inhibitor of Telomerase</article-title>. <source>Nature genetics</source>. <year>2015</year>;<volume>11</volume>(<issue>6</issue>):<fpage>e1005286</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pgen.1005286" xlink:type="simple">10.1371/journal.pgen.1005286</ext-link></comment> <object-id pub-id-type="pmid">26053551</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nencha</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Rahimian</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Giry</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sechi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Mokhtari</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Polivka</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas</article-title>. <source>Journal of Neuro-Oncology</source>. <year>2016</year>;<volume>126</volume>(<issue>3</issue>):<fpage>441</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11060-015-1999-3" xlink:type="simple">10.1007/s11060-015-1999-3</ext-link></comment> <object-id pub-id-type="pmid">26608520</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Park</surname> <given-names>CK</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>JY</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>TM</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>ST</given-names></name>, <etal>et al</etal>. <article-title>Expression level of hTERT is regulated by somatic mutation and common single nucleotide polymorphism at promoter region in glioblastoma</article-title>. <source>Oncotarget</source>. <year>2014</year>;<volume>5</volume>(<issue>10</issue>):<fpage>3399</fpage>–<lpage>407</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.1975" xlink:type="simple">10.18632/oncotarget.1975</ext-link></comment> <object-id pub-id-type="pmid">24930669</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moher</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Liberati</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Tetzlaff</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>. <article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title>. <source>International journal of surgery (London, England)</source>. <year>2010</year>;<volume>8</volume>(<issue>5</issue>):<fpage>336</fpage>–<lpage>41</lpage> <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijsu.2010.02.007" xlink:type="simple">10.1016/j.ijsu.2010.02.007</ext-link></comment> <object-id pub-id-type="pmid">20171303</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname> <given-names>M</given-names></name>. <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source>. <year>1994</year>;<volume>50</volume>(<issue>4</issue>):<fpage>1088</fpage>–<lpage>101</lpage>. <object-id pub-id-type="pmid">7786990</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>GD</given-names></name>, <name name-style="western"><surname>Schneider</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname> <given-names>C</given-names></name>. <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ (Clinical research ed)</source>. <year>1997</year>;<volume>315</volume>(<issue>7109</issue>):<fpage>629</fpage>–<lpage>34</lpage>.</mixed-citation></ref>
<ref id="pone.0191560.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bayram</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Ulger</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Sumbul</surname> <given-names>AT</given-names></name>, <name name-style="western"><surname>Kaya</surname> <given-names>BY</given-names></name>, <name name-style="western"><surname>Genc</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Rencuzogullari</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Polymorphisms in human telomerase reverse transcriptase (hTERT) gene and susceptibility to gastric cancer in a Turkish population: Hospital-based case-control study</article-title>. <source>Gene</source>. <year>2016</year>;<volume>585</volume>(<issue>1</issue>):<fpage>84</fpage>–<lpage>92</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.gene.2016.03.030" xlink:type="simple">10.1016/j.gene.2016.03.030</ext-link></comment> <object-id pub-id-type="pmid">27016301</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jannuzzi</surname> <given-names>AT</given-names></name>, <name name-style="western"><surname>Karaman</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Oztas</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Yanar</surname> <given-names>HT</given-names></name>, <name name-style="western"><surname>Ozhan</surname> <given-names>G</given-names></name>. <article-title>Telomerase Reverse Transcriptase (TERT) Gene Variations and Susceptibility of Colorectal Cancer</article-title>. <source>Genetic testing and molecular biomarkers</source>. <year>2015</year>;<volume>19</volume>(<issue>12</issue>):<fpage>692</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/gtmb.2015.0150" xlink:type="simple">10.1089/gtmb.2015.0150</ext-link></comment> <object-id pub-id-type="pmid">26501986</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Wei</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Sturgis</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Wei</surname> <given-names>Q</given-names></name>. <article-title>Telomere length and TERT functional polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck</article-title>. <source>Cancer epidemiology, biomarkers &amp; prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</source>. <year>2011</year>;<volume>20</volume>(<issue>12</issue>):<fpage>2642</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/1055-9965.EPI-11-0890" xlink:type="simple">10.1158/1055-9965.EPI-11-0890</ext-link></comment> <object-id pub-id-type="pmid">21994403</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mosrati</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Malmstrom</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Lysiak</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Krysztofiak</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hallbeck</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Milos</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma</article-title>. <source>Oncotarget</source>. <year>2015</year>;<volume>6</volume>(<issue>18</issue>):<fpage>16663</fpage>–<lpage>73</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.4389" xlink:type="simple">10.18632/oncotarget.4389</ext-link></comment> <object-id pub-id-type="pmid">26143636</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mosrati</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Willander</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Falk</surname> <given-names>IJ</given-names></name>, <name name-style="western"><surname>Hermanson</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hoglund</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Stockelberg</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis</article-title>. <source>Oncotarget</source>. <year>2015</year>;<volume>6</volume>(<issue>28</issue>):<fpage>25109</fpage>–<lpage>20</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.4668" xlink:type="simple">10.18632/oncotarget.4668</ext-link></comment> <object-id pub-id-type="pmid">26298771</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Oztas</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Kara</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kara</surname> <given-names>ZP</given-names></name>, <name name-style="western"><surname>Aydogan</surname> <given-names>MU</given-names></name>, <name name-style="western"><surname>Uras</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Ozhan</surname> <given-names>G</given-names></name>. <article-title>Association Between Human Telomerase Reverse Transcriptase Gene Variations and Risk of Developing Breast Cancer</article-title>. <source>Genetic testing and molecular biomarkers</source>. <year>2016</year>;<volume>20</volume>(<issue>8</issue>):<fpage>459</fpage>–<lpage>64</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/gtmb.2015.0339" xlink:type="simple">10.1089/gtmb.2015.0339</ext-link></comment> <object-id pub-id-type="pmid">27336831</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Savage</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Chanock</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Lissowska</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Brinton</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Richesson</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Peplonska</surname> <given-names>B</given-names></name>, <etal>et al</etal>. <article-title>Genetic variation in five genes important in telomere biology and risk for breast cancer</article-title>. <source>British journal of cancer</source>. <year>2007</year>;<volume>97</volume>(<issue>6</issue>):<fpage>832</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/sj.bjc.6603934" xlink:type="simple">10.1038/sj.bjc.6603934</ext-link></comment> <object-id pub-id-type="pmid">17848914</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shadrina</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Boyarskikh</surname> <given-names>UA</given-names></name>, <name name-style="western"><surname>Oskina</surname> <given-names>NA</given-names></name>, <name name-style="western"><surname>Sinkina</surname> <given-names>TV</given-names></name>, <name name-style="western"><surname>Lazarev</surname> <given-names>AF</given-names></name>, <name name-style="western"><surname>Petrova</surname> <given-names>VD</given-names></name>, <etal>et al</etal>. <article-title>TERT polymorphisms rs2853669 and rs7726159 influence on prostate cancer risk in Russian population</article-title>. <source>Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine</source>. <year>2015</year>;<volume>36</volume>(<issue>2</issue>):<fpage>841</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s13277-014-2688-0" xlink:type="simple">10.1007/s13277-014-2688-0</ext-link></comment> <object-id pub-id-type="pmid">25296732</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Gammon</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>HC</given-names></name>, <name name-style="western"><surname>Terry</surname> <given-names>MB</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Bradshaw</surname> <given-names>PT</given-names></name>, <etal>et al</etal>. <article-title>Multiple genetic variants in telomere pathway genes and breast cancer risk</article-title>. <source>Cancer epidemiology, biomarkers &amp; prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</source>. <year>2010</year>;<volume>19</volume>(<issue>1</issue>):<fpage>219</fpage>–<lpage>28</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/1055-9965.EPI-09-0771" xlink:type="simple">10.1158/1055-9965.EPI-09-0771</ext-link></comment> <object-id pub-id-type="pmid">20056641</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Varadi</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Brendle</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Grzybowska</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Johansson</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Enquist</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Butkiewicz</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer</article-title>. <source>Cancer genetics and cytogenetics</source>. <year>2009</year>;<volume>190</volume>(<issue>2</issue>):<fpage>71</fpage>–<lpage>4</lpage> <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cancergencyto.2008.12.006" xlink:type="simple">10.1016/j.cancergencyto.2008.12.006</ext-link></comment> <object-id pub-id-type="pmid">19380022</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xing</surname> <given-names>YL</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>GD</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Case–Control Study on Impact of the Telomerase Reverse Transcriptase Gene Polymorphism and Additional Single Nucleotide Polymorphism (SNP)–SNP Interaction on Non-Small Cell Lung Cancers Risk in Chinese Han Population</article-title>. <source>Journal of clinical laboratory analysis</source>, <year>2016</year>, <volume>30</volume>(<issue>6</issue>): <fpage>1071</fpage>–<lpage>1077</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jcla.21982" xlink:type="simple">10.1002/jcla.21982</ext-link></comment> <object-id pub-id-type="pmid">27154632</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yoo</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Do</surname> <given-names>SK</given-names></name>, <name name-style="western"><surname>Choi</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>SY</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Cha</surname> <given-names>SI</given-names></name>, <etal>et al</etal>. <article-title>TERT Polymorphism rs2853669 Influences on Lung Cancer Risk in the Korean Population</article-title>. <source>Journal of Korean medical science</source>. <year>2015</year>;<volume>30</volume>(<issue>10</issue>):<fpage>1423</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3346/jkms.2015.30.10.1423" xlink:type="simple">10.3346/jkms.2015.30.10.1423</ext-link></comment> <object-id pub-id-type="pmid">26425038</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhong</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Zou</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>B</given-names></name>, <etal>et al</etal>. <article-title>Genetic variations in TERT-CLPTM1L locus are associated with risk of lung cancer in chinese population</article-title>. <source>Mol Carcinogen</source>. <year>2013</year>;<volume>52</volume>(<issue>SUPPL1</issue>):<fpage>118</fpage>–<lpage>26</lpage>.</mixed-citation></ref>
<ref id="pone.0191560.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yamaguchi</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Calado</surname> <given-names>RT</given-names></name>, <name name-style="western"><surname>Ly</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kajigaya</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Baerlocher</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Chanock</surname> <given-names>SJ</given-names></name>, <etal>et al</etal>. <article-title>Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia</article-title>. <source>New Engl J Med</source>. <year>2005</year>;<volume>352</volume>(<issue>14</issue>):<fpage>1413</fpage>–<lpage>24</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa042980" xlink:type="simple">10.1056/NEJMoa042980</ext-link></comment> <object-id pub-id-type="pmid">15814878</object-id></mixed-citation></ref>
<ref id="pone.0191560.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Blasco</surname> <given-names>MA</given-names></name>. <article-title>Telomeres and human disease: ageing, cancer and beyond</article-title>. <source>Nat Rev Genet</source>. <year>2005</year>;<volume>6</volume>(<issue>8</issue>):<fpage>611</fpage>–<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrg1656" xlink:type="simple">10.1038/nrg1656</ext-link></comment> <object-id pub-id-type="pmid">16136653</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wu</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Qi</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Association of genetic polymorphisms in the telomerase reverse transcriptase gene with prostate cancer aggressiveness</article-title>. <source>Molecular medicine reports</source>. <year>2015</year>;<volume>12</volume>(<issue>1</issue>):<fpage>489</fpage>–<lpage>97</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3892/mmr.2015.3410" xlink:type="simple">10.3892/mmr.2015.3410</ext-link></comment> <object-id pub-id-type="pmid">25738283</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Horikawa</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Barrett</surname> <given-names>JC</given-names></name>. <article-title>Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms</article-title>. <source>Carcinogenesis</source>. <year>2003</year>;<volume>24</volume>(<issue>7</issue>):<fpage>1167</fpage>–<lpage>76</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/carcin/bgg085" xlink:type="simple">10.1093/carcin/bgg085</ext-link></comment> <object-id pub-id-type="pmid">12807729</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Harley</surname> <given-names>CB</given-names></name>. <article-title>Telomerase and cancer therapeutics</article-title>. <source>Nat Rev Cancer</source>. <year>2008</year>;<volume>8</volume>(<issue>3</issue>):<fpage>167</fpage>–<lpage>79</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrc2275" xlink:type="simple">10.1038/nrc2275</ext-link></comment> <object-id pub-id-type="pmid">18256617</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vinagre</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Pinto</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Celestino</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Reis</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Populo</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Boaventura</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Telomerase promoter mutations in cancer: an emerging molecular biomarker?</article-title> <source>Virchows Archiv: an international journal of pathology</source>. <year>2014</year>;<volume>465</volume>(<issue>2</issue>):<fpage>119</fpage>–<lpage>33</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00428-014-1608-4" xlink:type="simple">10.1007/s00428-014-1608-4</ext-link></comment> <object-id pub-id-type="pmid">25048572</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Borah</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Xi</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Zaug</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Powell</surname> <given-names>NM</given-names></name>, <name name-style="western"><surname>Dancik</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Cohen</surname> <given-names>SB</given-names></name>, <etal>et al</etal>. <article-title>TERT promoter mutations and telomerase reactivation in urothelial cancer</article-title>. <source>Science</source>. <year>2015</year>;<volume>347</volume>(<issue>6225</issue>):<fpage>1006</fpage>–<lpage>10</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1260200" xlink:type="simple">10.1126/science.1260200</ext-link></comment> <object-id pub-id-type="pmid">25722414</object-id></mixed-citation></ref>
<ref id="pone.0191560.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cukusic</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Skrobot Vidacek</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Sopta</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Rubelj</surname> <given-names>I</given-names></name>. <article-title>Telomerase regulation at the crossroads of cell fate</article-title>. <source>Cytogenet Genome Res</source>. <year>2008</year>;<volume>122</volume>(<issue>3–4</issue>):<fpage>263</fpage>–<lpage>72</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1159/000167812" xlink:type="simple">10.1159/000167812</ext-link></comment> <object-id pub-id-type="pmid">19188695</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hsu</surname> <given-names>CP</given-names></name>, <name name-style="western"><surname>Hsu</surname> <given-names>NY</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>LW</given-names></name>, <name name-style="western"><surname>Ko</surname> <given-names>JL</given-names></name>. <article-title>Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter—effect on telomerase expression and telomere length maintenance in non-small cell lung cancer</article-title>. <source>European journal of cancer (Oxford, England: 1990)</source>. <year>2006</year>;<volume>42</volume>(<issue>10</issue>):<fpage>1466</fpage>–<lpage>74</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ejca.2006.02.014" xlink:type="simple">10.1016/j.ejca.2006.02.014</ext-link></comment> <object-id pub-id-type="pmid">16737810</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nencha</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Rahimian</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Giry</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sechi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Mokhtari</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Polivka</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas</article-title>. <source>J Neurooncol</source>. <year>2016</year>;<volume>126</volume>(<issue>3</issue>):<fpage>441</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11060-015-1999-3" xlink:type="simple">10.1007/s11060-015-1999-3</ext-link></comment> <object-id pub-id-type="pmid">26608520</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ko</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Seo</surname> <given-names>HW</given-names></name>, <name name-style="western"><surname>Jung</surname> <given-names>ES</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>BH</given-names></name>, <name name-style="western"><surname>Jung</surname> <given-names>G</given-names></name>. <article-title>The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer</article-title>. <source>Oncotarget</source>. <year>2016</year>;<volume>7</volume>(<issue>1</issue>):<fpage>684</fpage>–<lpage>99</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.6331" xlink:type="simple">10.18632/oncotarget.6331</ext-link></comment> <object-id pub-id-type="pmid">26575952</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hosen</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Rachakonda</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Heidenreich</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Sitaram</surname> <given-names>RT</given-names></name>, <name name-style="western"><surname>Ljungberg</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Roos</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>TERT promoter mutations in clear cell renal cell carcinoma</article-title>. <source>International journal of cancer</source>. <year>2015</year>;<volume>136</volume>(<issue>10</issue>):<fpage>2448</fpage>–<lpage>52</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ijc.29279" xlink:type="simple">10.1002/ijc.29279</ext-link></comment> <object-id pub-id-type="pmid">25331263</object-id>.</mixed-citation></ref>
<ref id="pone.0191560.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>ZY</given-names></name>, <name name-style="western"><surname>Dong</surname> <given-names>YL</given-names></name>, <name name-style="western"><surname>Feng</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Cao</surname> <given-names>XZ</given-names></name>. <article-title>Polymorphisms in the telomerase reverse transcriptase promoter are associated with risk of breast cancer: A meta-analysis</article-title>. <source>Journal of cancer research and therapeutics</source>. <year>2016</year>;<volume>12</volume>(<issue>2</issue>):<fpage>1040</fpage>–<lpage>4</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4103/0973-1482.164701" xlink:type="simple">10.4103/0973-1482.164701</ext-link></comment> <object-id pub-id-type="pmid">27461695</object-id>.</mixed-citation></ref>
</ref-list>
</back>
</article>